Drug intelligence / Profile preview

xiyanping injection + oseltamivir phosphate

Development stage
Unknown
Lead developer
Jiangxi Qingfeng Pharmaceutical
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Xiyanping injection + oseltamivir phosphate is a combination of two drugs used primarily for the treatment of acute viral infections, particularly influenza. Xiyanping injection is a traditional Chinese medicine preparation containing andrographolide sulfonate, which exhibits antiviral and anti-inflammatory properties and is commonly used in China for respiratory tract infections[3]. Oseltamivir phosphate is an oral antiviral medication that acts as a neuraminidase inhibitor, blocking the release of new influenza virus particles from infected cells and thereby limiting the spread of infection in the body[2][5]. Oseltamivir is approved for both treatment and prevention of influenza A and B in adults and children[1][4][6]. The combination may be considered to enhance antiviral efficacy during early stages of acute infection.

Brand names
Tamiflu
Other names
andrographolide sulfonate (for xiyanping injection)oseltamivir (for oseltamivir phosphate)
02

Targets

NeuraminidaseHSP90AA1 (Heat shock protein HSP90-alpha)

Beyond the preview

Go deeper on xiyanping injection + oseltamivir phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiyanping injection + oseltamivir phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call